Samuraciclib trihydrochloride
Product Specifications
Target
Others
Related Pathways
Others
Bioactivity
Samuraciclib (CT7001) trihydrochloride is a potent, selective, ATP-competitive and orally active CDK7 inhibitor, with an IC50 of 41 nM. Samuraciclib trihydrochloride displays 45-, 15-, 230- and 30-fold selectivity over CDK1, CDK2 (IC50 of 578 nM), CDK5 and CDK9, respectively. Samuraciclib trihydrochloride inhibits the growth of breast cancer cell lines with GI50 values between 0.2-0.3 ?M. Samuraciclib trihydrochloride has anti-tumor effects[1][2].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS450653-01 48 Tests
Human Serine Palmitoyltransferase, Long Chain Base Subunit 3 (SPTLC3) ELISA Kit
Ask
View Details